Skip to the page

Data / Form D filings / ASCELLA BIOSYSTEMS, INC.

ASCELLA BIOSYSTEMS, INC.: Form D filing

ASCELLA BIOSYSTEMS, INC., a health care company in San Francisco, CA, filed a Form D with the SEC in 2023. The latest, on December 28, 2023, reports $6.3 million sold of a $6.3 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
150 HOOPER STREET, SUITE 212, San Francisco, CA, 94107
Phone
(650) 832-1142
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2006111

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 28, 2023New notice$6,331,965$6,331,96511Dec 18, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
JUNICHI KAJIMOTOExecutive Officer, Director
SATORU IINODirector
DEEPAK BOGGAVARAPUExecutive Officer, Director, Promoter

Other health care companies in California that filed recently

Every Form D from the week of Dec 25, 2023 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ASCELLA BIOSYSTEMS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.